ClinicalTrials.gg

Program

PA5108

A development code. Also written as “PA5108 Ocular Implant low dose”, “PA5108 Ocular Implant, high dose” and “PA5108 Latanoprost FA SR Ocular Implant”.

Its studies are mostly in Glaucoma, Open-Angle, led by PolyActiva Pty.

Furthest: phase 2, since Mar 25, 20253 company-led studies, 1 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
PolyActiva Pty31 open or runningphase 2since Mar 25, 2025Jul 10, 2018none ahead

Also a collaborator on its studies: iuvo-s-r-l.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Jul 10, 2018First study: phase 1 study in Glaucoma, Open-AngleFirst studyNCT03604328 · 8 enrolled · Australia
  2. Aug 5, 2019Phase 1 study in Glaucoma, Open-AngleNCT04060758 · 37 enrolled · Australia, New Zealand
  3. Mar 25, 2025Phase 2 study in Glaucoma, Open-AngleNCT06964191 · 75 enrolled · United States

Ahead

  1. Nov 15, 2026Primary completion: phase 2 study in Glaucoma, Open-AngleNCT06964191

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 3 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT06964191Glaucoma, Open-Angle · United States2Active, not recruitingNov 15, 202675
NCT04060758Glaucoma, Open-Angle · Australia, New Zealand1CompletedMay 13, 202537
NCT03604328Glaucoma, Open-Angle · Australia1CompletedJun 15, 20208

How it is read

Names in the registry

  • “PA5108 Ocular Implant low dose”, 1 entry
  • “PA5108 Ocular Implant, high dose”, 1 entry
  • “PA5108 Latanoprost FA SR Ocular Implant”, 1 entry
  • “PA5108”, 1 entry

Codes read as this program: PA5108.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.